Profluent
Profluent is seeking an Associate Director - Director to lead in vivo pharmacology strategy and execution for customized base editor therapeutics, overseeing rodent and non‑human primate studies to evaluate editing activity, delivery, biodistribution, durability, tolerability, and translational potential. The role involves cross‑functional collaboration with gene editing, protein engineering, delivery, computational biology, bioanalytics, and external CROs to generate decision‑quality data that guides candidate selection and IND‑enabling development.
Headquarters
Emeryville, California, United States
Company Size
11-50 employees
Founded
2022
Profluent is an AI-driven protein design company that uses generative machine learning to author novel proteins, either inspired by natural scaffolds or designed from scratch. Its flagship achievement is OpenCRISPR, the world's first AI-designed gene editor, and its platform enables applications across therapeutics, industrial enzymes, and beyond. Profluent partners with organizations such as Eli Lilly to translate AI-authored protein designs into real-world solutions across medicine, agriculture, and other industries.
Profluent Raises $106M to Scale Frontier AI Models for Programmable Biology
Nov 19, 2025
Profluent Secures $106M Funding to Enhance AI-Driven Biology Solutions
Nov 25, 2025
AI for crop engineering: Corteva, Profluent Bio partner to develop gene editing tools
Oct 7, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Profluent.
Right around the average for this role
AI biotech Profluent closes $106M raise with Jeff Bezos’ support
Nov 19, 2025
Associate Scientist
Regeneron Pharmaceuticals
Director of In Vivo Pharmacology
Flagship Pioneering, Inc.
Pioneering Medicines: Principal Scientist / Associate Director , Non-Clinical Pharmacology
Flagship Pioneering, Inc.
Senior Director, In Vivo Pharmacology
Generate:Biomedicines
Sr. Director, Pharmacology
Cellarity
Sr. Director, Pharmacology
Flagship Pioneering, Inc.